Related Experiment Video
Updated: Aug 6, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Effect of an interferon stimulator, polyinosinic: polycytidylic acid, on experimental fungus infections
Abstract:
IN THE PRESENT STUDY, THE ADMINISTRATION OF AN INTERFERON STIMULATOR, POLYINOSINIC: polycytidylic acid (In:Cn), increased the severity of both experimental Candida albicans and Coccidioides immitis infections in mice, as evidenced by earlier time of death and higher final mortality. In addition, kidney tissue levels of C. albicans at 3 and 5 days after infection were found to be about 40- to 300-fold higher in In:Cn treated mice than in control mice. Experimental Cryptococcus neoformans infection, however, was not significantly affected by In:Cn treatment.
Insights
Polyinosinic:polycytidylic acid (In:Cn), an interferon stimulator, worsened experimental fungal infections in mice. In:Cn treatment led to increased mortality and fungal burden for Candida albicans and Coccidioides immitis infections.
Area of Science:
- Immunology
- Mycology
- Infectious Diseases
Background:
- Interferon stimulators modulate immune responses.
- Fungal infections pose significant health challenges.
Purpose of the Study:
- To investigate the effect of polyinosinic:polycytidylic acid (In:Cn) on experimental fungal infections.
- To determine if In:Cn influences the severity of Candida albicans, Coccidioides immitis, and Cryptococcus neoformans infections.
Main Methods:
- Administration of In:Cn to mice prior to fungal challenge.
- Monitoring survival rates and mortality.
- Quantifying fungal burden in infected tissues (kidneys).
Main Results:
- In:Cn treatment significantly increased mortality and fungal burden in mice infected with Candida albicans and Coccidioides immitis.
- Kidney tissue fungal load for Candida albicans was 40- to 300-fold higher in In:Cn treated mice.
- Cryptococcus neoformans infection severity was not significantly altered by In:Cn treatment.
Conclusions:
- In:Cn exacerbates certain experimental fungal infections in mice.
- The impact of In:Cn on fungal infections may be pathogen-specific.
- Further research is needed to understand the mechanisms behind In:Cn's differential effects.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antifungal Agents

